Your prediction
Protalix Biotherapeutics Inc. Stock
There is an upward development for Protalix Biotherapeutics Inc. compared to yesterday, with an increase of €0.030 (1.690%).
Our community identified positive and negative aspects for Protalix Biotherapeutics Inc. stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Protalix Biotherapeutics Inc. stock. On the other hand our users think that "Growth compared to competition" could be a problem in the future.
Pros and Cons of Protalix Biotherapeutics Inc. in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
B****
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Protalix Biotherapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Protalix Biotherapeutics Inc. | 1.690% | -0.565% | 15.033% | -16.230% | 15.033% | 11.357% | -49.714% |
| Compugen Ltd. | 8.040% | 45.299% | 57.895% | -7.062% | 55.015% | 130.508% | - |
| Chromadex Corp | -1.850% | -5.357% | 0.952% | -1.852% | -3.636% | 204.248% | 38.021% |
| Intellia Therapeutics Inc | -1.530% | 20.603% | 42.169% | 16.378% | 37.907% | -67.789% | -84.808% |
